WASHINGTON, April 11 -- The Environmental Protection Agency issued the following news release: * * * Connecticut Firm Complies with Federal Lead Paint Laws after EPA Inspection BOSTON (April 9, 2025) - The U.S. Environmental Protection Agency (EPA) today announced a settlement with Precision Property Management LLC that includes a $40,339 civil penalty and an agreement by the company to maintain compliance with federal laws that help protect residents from the risks of lead paint exposure. EP  more

BOSTON, Massachusetts, April 10 -- Gov. Maura Healey, D-Massachusetts, issued the following news release: * * * Massachusetts Community Climate Bank and Partners Launch Massachusetts Energy Savings Finder Boston -- Today, the Healey-Driscoll Administration is announcing that the Massachusetts Community Climate Bank (MCCB), in partnership with Rewiring America, Abode Energy Management and a coalition of state government and energy efficiency program partners, is launching the first-ever Massac  more

WASHINGTON, April 10 -- Rep. Seth Moulton, D-Massachusetts, issued the following news release: * * * Moulton and Massachusetts Delegation Demand Answers on the Sudden Closure of the U.S. Department of Health and Human Services Regional Office in Boston Washington, D.C. - Congressman Moulton (MA-06) and the entire Massachusetts Congressional delegation - Senator Elizabeth Warren (D-Mass.), Senator Edward J. Markey (D-Mass.), and Representatives Richard Neal (MA-01), Jim McGovern (MA-02), Lori   more

WASHINGTON, April 10 -- Rep. Seth Moulton, D-Massachusetts, issued the following news release: * * * Newsletter: Trump's Tariffs, Calling Out DOGE, and More Updates Dear Friends, Strong trading relationships with our allies give Americans access to a wider variety of goods at lower prices, from cars to laptops to dishwashers. President Trump is severely jeopardizing the entire global system--and our economy--with his tariffs. I'm extremely concerned that things will rapidly get worse. The  more

NEW YORK, April 11 -- The National Multiple Sclerosis Society issued the following news on April 10, 2025: * * * Tolebrutinib Phase 3 Studies Published, Supporting Review by FDA for Treating Nonrelapsing Secondary Progressive MS The phase 3 studies of oral BTK-inhibitor tolebrutinib have been published in The New England Journal of Medicine. The results provide evidence for tolebrutinib as an effective treatment for nonrelapsing secondary progressive MS* - a type of MS for which no treatment   more